Preserving Access to Orphan Drugs Act of 2015
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Oct 1, 2015)
Preserving Access to Orphan Drugs Act of 2015
This bill amends the Patient Protection and Affordable Care Act to expand the definition of orphan drug for purposes of the annual fee paid by brand name prescription drug manufacturers and importers to include medications for rare conditions that were, prior to 2011, approved or in clinical trials. (Drug manufacturers and importers pay an annual fee based on their sales of brand name prescription drugs, excluding sales of orphan drugs.) Currently, only medications for rare conditions for which a tax credit for clinical trials was allowed are considered orphan drugs.
This Act applies to fees paid after 2014.What just happenedOct 2, 2015
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseOct 1, 2015
- Oct 2, 2015Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Oct 1, 2015Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Oct 1, 2015IntroReferralH11100
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Oct 1, 2015IntroReferralH11100-A
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Oct 1, 2015IntroReferralH11100
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Oct 1, 2015IntroReferralIntro-H
Introduced in House
- Oct 1, 2015IntroReferral1000
Introduced in House